TIDES Europe: Oligonucleotide and Peptide Therapeutics 2027
TIDES Europe is the European edition of the TIDES conference on oligonucleotide and peptide therapeutics. It's attended by R&D scientists, CMC and regulatory specialists and business development teams.
Dates not announced yet
Check the official site for updates
Organizer
Published by the organizer
Every year
How often it's held
Checked November 6, 2026
About TIDES Europe: Oligonucleotide and Peptide Therapeutics 2027
TIDES Europe is an annual conference on oligonucleotide and peptide therapeutics, run by Informa Connect. Its latest edition ran 3 to 5 November 2026 at the RAI Amsterdam Convention Centre. Dates and a venue for TIDES Europe 2027 aren't announced yet, and the TIDES series calendar shows no European date beyond 2026. It's built for drug developers, CMC teams, regulatory specialists and the service providers who make these molecules. The organizer says the 2025 edition welcomed over 900 attendees.
135
Speakers listed (our count)
28
Sponsors listed (our count)
72
Exhibitors listed (our count)
3
Content tracks
3
Pre-conference workshops
What happens at TIDES Europe
TIDES Europe is three days of scientific talks, workshops and an exhibit hall. The 2026 program covered oligonucleotides, peptides, mRNA, drug delivery and partnering, from discovery to market.
The 2026 edition opened with three pre-conference workshops on the morning of 3 November. Two covered oligonucleotide CMC and cost of goods, and one covered peptide manufacturing and purification.
Keynotes from Eli Lilly, Novo Nordisk, the University of Würzburg and ProQR Therapeutics filled the opening afternoon plenary. The poster and exhibit hall opened that afternoon, followed by an evening reception.
On 4 and 5 November the program split into three parallel tracks. They were Oligonucleotide Discovery, Preclinical and Clinical, Oligonucleotide Chemistry, Manufacturing and Controls, and Peptide Discovery to CMC.
Sponsor spotlight talks, TIDES Talks in the exhibit hall and an offsite Winter Market reception filled the second day. The conference closed on 5 November 2026.
Delegates could also add the Obesity Science & Innovation Europe symposium on 6 November 2026. It covered GLP-1 therapies and RNA-based approaches to obesity at nhow Amsterdam RAI.
The organizer hasn't published a program for the 2027 edition yet.
What's new for TIDES Europe 2027
Informa Connect hasn't announced anything new for TIDES Europe 2027 yet. The event home page still describes the 2026 edition.
The 2026 edition brought a new city, new sessions and a post-event symposium. Keynotes from Eli Lilly and Novo Nordisk covered GLP-1 therapeutics.
New 2026 sessions covered innovations in peptide discovery and targeted delivery of oligonucleotides. Two new workshops focused on oligonucleotide cost of goods and lifecycle CMC.
A new emerging European company track featured firms that hadn't spoken at TIDES before. They included smartRNA, Inverna Therapeutics, Cognigenics, SQY Therapeutics, Orfonyx Bio and noctuRNA Therapeutics.
Obesity Science & Innovation Europe was new in 2026 as a one-day add-on on 6 November.
Who attends TIDES Europe
TIDES Europe draws scientists and managers who develop and make oligonucleotide and peptide drugs. The official FAQ names R&D scientists, CMC specialists, regulatory affairs staff, business development executives and academic researchers.
- Diamond1
- Platinum4
- Gold1
- Silver7
- Bronze15
Our count of the official 2026 sponsor list, 1 November 20262026 · informaconnect.com ↗
The same FAQ says attendees come from major pharma companies, emerging biotechs, academic institutions and service providers. The organizer doesn't publish a breakdown by job function, country or company size.
Audience size depends on the source. The organizer says the 2025 Basel edition welcomed over 900 attendees. A pre-event preview in Nucleic Acid Insights expected over 750 attendees and over 100 speakers in 2025.
The organizer hasn't published an attendance figure for the 2026 Amsterdam edition since it closed.
The same series runs TIDES USA in Boston in April 2027. Teams in pharma outsourcing may also look at CPHI Worldwide.
Attendance and exhibitors by year
As the organizer reports them. What's counted varies between events, so compare with care.
| Edition | Attendance |
|---|---|
| 2025 | 900+attendeesOrganizer's recap of the 2025 Basel editioninformaconnect.com ↗ |
Companies at TIDES Europe
TIDES Europe 2027 exhibitors and sponsors aren't announced yet, so this list covers the 2026 edition. Contract manufacturers and suppliers of synthesis, purification and analytical tools made up most of the 2026 sponsor and exhibitor list.
Sponsors (28)Asymchem, Agilent Technologies, Axolabs and 25 more
- Asymchem · 2026Diamond sponsor, 2026
- Agilent Technologies · 2026Platinum sponsor, 2026
- Axolabs · 2026Platinum sponsor, 2026
- Bachem · 2026Platinum sponsor, 2026
- WuXi TIDES · 2026Platinum sponsor, 2026
- ST Pharm · 2026Gold sponsor, 2026
- Asahi Kasei Bioprocess · 2026Silver sponsor, 2026
- Bio-Techne Spatial · 2026Silver sponsor, 2026
- Codexis · 2026Silver sponsor, 2026
- Corden Pharma · 2026Silver sponsor, 2026
- Cytiva · 2026Silver sponsor, 2026
- Nitto Avecia · 2026Silver sponsor, 2026
- PolyPeptide Group · 2026Silver sponsor, 2026
- Ajinomoto Bio-Pharma Services · 2026Bronze sponsor, 2026
- Bruker · 2026Bronze sponsor, 2026
- Catalent · 2026Bronze sponsor, 2026
- Croda · 2026Bronze sponsor, 2026
- DuPont · 2026Bronze sponsor, 2026
- emp Biotech · 2026Bronze sponsor, 2026
- Fluid Air · 2026Bronze sponsor, 2026
- Hongene · 2026Bronze sponsor, 2026
- Neuland Labs · 2026Bronze sponsor, 2026
- SCIEX · 2026Bronze sponsor, 2026
- SK Pharmteco · 2026Bronze sponsor, 2026
- Syngene · 2026Bronze sponsor, 2026
- Thermo Fisher Scientific · 2026Bronze sponsor, 2026
- Tosoh Bioscience · 2026Bronze sponsor, 2026
- W.L. Gore · 2026Bronze sponsor, 2026
Exhibitors (72)ADS Biotec, Almac Group, AnaBioTec and 69 more
- ADS Biotec · 2026Listed exhibitor, 2026
- Almac Group · 2026Listed exhibitor, 2026
- AnaBioTec · 2026Listed exhibitor, 2026
- Apeloa Pharmaceutical · 2026Listed exhibitor, 2026
- Apextide · 2026Listed exhibitor, 2026
- Baishixing Science & Technology (Chengdu) · 2026Listed exhibitor, 2026
- BCN Peptides · 2026Listed exhibitor, 2026
- Biocytogen · 2026Listed exhibitor, 2026
- BioPharmaSpec · 2026Listed exhibitor, 2026
- Biosolve Life sciences · 2026Listed exhibitor, 2026
- BioSpring · 2026Listed exhibitor, 2026
- Cambrex · 2026Listed exhibitor, 2026
- CEM · 2026Listed exhibitor, 2026
- ChemGenes · 2026Listed exhibitor, 2026
- Chengdu ZY Biochemical · 2026Listed exhibitor, 2026
- CPC Scientifc · 2026Listed exhibitor, 2026
- CSBio · 2026Listed exhibitor, 2026
- Desano · 2026Listed exhibitor, 2026
- Divi's Laboratories · 2026Listed exhibitor, 2026
- Eazy Pharmchem · 2026Listed exhibitor, 2026
- EUROAPI · 2026Listed exhibitor, 2026
- Fresenius Kabi · 2026Listed exhibitor, 2026
- Glycogene · 2026Listed exhibitor, 2026
- Hanbon Science & Technology · 2026Listed exhibitor, 2026
- Honour Lab · 2026Listed exhibitor, 2026
- Hunan Honya · 2026Listed exhibitor, 2026
- Hybio International · 2026Listed exhibitor, 2026
- Inabata · 2026Listed exhibitor, 2026
- Intellegens · 2026Listed exhibitor, 2026
- Intertek · 2026Listed exhibitor, 2026
- Jiuzhou Pharma · 2026Listed exhibitor, 2026
- Shenzhen JYMed Technology · 2026Listed exhibitor, 2026
- Kezx Biotechnology · 2026Listed exhibitor, 2026
- Kinovate Life Sciences · 2026Listed exhibitor, 2026
- KNAUER · 2026Listed exhibitor, 2026
- Laurus Labs · 2026Listed exhibitor, 2026
- LGC Biosearch Technologies · 2026Listed exhibitor, 2026
- Milestone · 2026Listed exhibitor, 2026
- Morning Shine Pharm (Changsha) · 2026Listed exhibitor, 2026
- Nankai Heceing S&T Co Ltd (Tianjin Nankai) · 2026Listed exhibitor, 2026
- NanoMicro Technologies · 2026Listed exhibitor, 2026
- NIPPON SHOKUBAI · 2026Listed exhibitor, 2026
- OmniAb · 2026Listed exhibitor, 2026
- PeptiSystems · 2026Listed exhibitor, 2026
- PharmaBlock · 2026Listed exhibitor, 2026
- Pharmaron · 2026Listed exhibitor, 2026
- Poresyn · 2026Listed exhibitor, 2026
- Pukang Biotechnology · 2026Listed exhibitor, 2026
- Quality Assistance · 2026Listed exhibitor, 2026
- Ribobay · 2026Listed exhibitor, 2026
- RiboBio · 2026Listed exhibitor, 2026
- Sapala Organics · 2026Listed exhibitor, 2026
- Scharlab · 2026Listed exhibitor, 2026
- Senn Chemicals · 2026Listed exhibitor, 2026
- Sichuan Tongsheng · 2026Listed exhibitor, 2026
- Sierra Bio · 2026Listed exhibitor, 2026
- Space Peptides · 2026Listed exhibitor, 2026
- Sumitomo Chemical Co Ltd · 2026Listed exhibitor, 2026
- Sylentis · 2026Listed exhibitor, 2026
- SynCrest · 2026Listed exhibitor, 2026
- Syngene · 2026Listed exhibitor, 2026
- Synoligo Biotechnologies · 2026Listed exhibitor, 2026
- TAPI · 2026Listed exhibitor, 2026
- U-genes · 2026Listed exhibitor, 2026
- Vazyme · 2026Listed exhibitor, 2026
- Waters · 2026Listed exhibitor, 2026
- Wuhu Huaren Science & Technology · 2026Listed exhibitor, 2026
- WuXi XDC · 2026Listed exhibitor, 2026
- Yamasa · 2026Listed exhibitor, 2026
- Yaohai Bio-Pharmaceutical · 2026Listed exhibitor, 2026
- YMC ChromaCon · 2026Listed exhibitor, 2026
- Zheijiang Peptites · 2026Listed exhibitor, 2026
Speakers' companies (8)Eli Lilly and Company, Novo Nordisk, ProQR Therapeutics and 5 more
- Eli Lilly and Company · 2026Two keynotes on 3 November 2026
- Novo Nordisk · 2026GLP-1 keynote on 3 November 2026
- ProQR Therapeutics · 2026RNA editing keynote on 3 November 2026
- Alnylam Pharmaceuticals · 2026RNAi pipeline and siRNA manufacturing talks, 2026
- AstraZeneca · 2026Several speakers across the 2026 tracks
- F. Hoffmann-La Roche · 2026Regulatory and oligonucleotide speakers, 2026
- Sanofi · 2026mRNA delivery speaker, 2026
- Ionis Pharmaceuticals · 2026CMC regulatory talk, 2026
Drug developers mostly appeared as speakers. Big pharma speakers in 2026 came from Eli Lilly, Novo Nordisk, AstraZeneca, Roche, Sanofi, Novartis, GSK and Bayer, per the official speaker list.
RNA biotechs such as Alnylam, Ionis, Wave Life Sciences and Silence Therapeutics also presented in 2026.
Exhibitors at TIDES Europe
The organizer hasn't published a 2027 exhibitor list yet. The 2026 exhibit hall held roughly 100 companies. Our count of the sponsors and exhibitors page on 1 November 2026 found 28 sponsors and 72 exhibitors.
The organizer's own 2026 figures varied by page. The home page cited 60+ exhibitors, while the registration page promised 90+ live booths.
Exhibitors in 2026 included peptide and oligonucleotide manufacturers, chromatography and analytical suppliers, and raw material makers.
Booths and private meeting rooms are sold through the sponsorship team. The why sponsor page lists speaking slots, branded items, exhibit booths and meeting rooms as options.
In 2026 sponsors and exhibitors got Lead Insights, a dashboard that ranks and scores their interactions with delegates. It works much like the lead retrieval apps used at larger trade shows.
The organizer's sponsor prospectus sits behind a request form, so stand prices aren't public.
Sponsors and partners at TIDES Europe
TIDES Europe runs a tiered sponsor program with five levels. The 2026 sponsor list showed one Diamond, four Platinum, one Gold, seven Silver and fifteen Bronze sponsors.
Asymchem was the 2026 Diamond sponsor. Agilent Technologies, Axolabs, Bachem and WuXi TIDES held Platinum, and ST Pharm held Gold. No 2027 sponsors are named yet.
Sponsorship covers more than the conference itself. The why sponsor page also sells webinars, newsletter advertising, content programs and list rental across the TIDES series.
Media partners in 2026 included the Royal Society of Chemistry, Biopharma Asia, Nucleic Acid Insights and CIPPS, per the official partner list. Teams comparing tools can read our guide to event sponsorship software.
The event's tech
We couldn't identify a third-party registration platform on the event's website.
TIDES Europe attendee list, exhibitor list and sponsor list
Exhibitor list
Published
Sponsor list
Published
Attendee list
Not published or sold
The official exhibitor and sponsor lists share one sponsors and exhibitors page, which still shows the 2026 edition. It gives company names by tier but no booth numbers or contact details.
Registered attendees get the ConnectMe app, which shows who else is attending. Users can filter by name, company, interests and attendee type, then message and book meetings.
For 2026, ConnectMe opened four weeks before the event. Every in-person pass on the booking page included the full attendee list inside the platform, with chat and meeting requests.
The site also offers a title and company attendee list download through a request form. It doesn't sell a contact list of delegates.
The organizer warns that unofficial housing firms may contact attendees. Its 2026 hotel fraud advisory said RAI Hotel Services was the only official housing partner.
Our guide on how to find who's attending an event explains what organizers share. We also compare event intelligence platforms that track companies at events.
See who's attending TIDES Europe: Oligonucleotide and Peptide Therapeutics
Organizers don't publish attendee lists. These event intelligence platforms show which companies and roles are likely to attend and help you book meetings. How to find who's attending
Speakers at TIDES Europe 2027
TIDES Europe hasn't announced its 2027 speakers yet. The TIDES series page takes speaking proposals for upcoming events through a form.
TIDES Europe: Oligonucleotide and Peptide Therapeutics hasn't announced its 2027 speakers yet. Below is who spoke at past editions.
The 2026 lineup was large. The official speaker page listed 135 speakers when we counted on 1 November 2026.
At the 2026 edition, the five keynotes on 3 November came from Eli Lilly, Novo Nordisk, the University of Würzburg and ProQR. Nour Fahmi and Michael Kopach spoke for Lilly, and Jacob Challand Kofoed for Novo Nordisk.
Peptide researcher David Craik of the University of Queensland chaired a new 2026 session on peptide discovery, the home page says. Paul Nioi of Alnylam presented the company's RNAi pipeline on the final day.
Regulators were on the 2026 program too. Eleonora Marino and Brian Dooley of the European Medicines Agency spoke in the day two tracks.
Delegates could present research as a poster in 2026, in person or digitally.
At the 2025 edition in Basel, Shalini Andersson of AstraZeneca and Chris Hart of Eli Lilly were among the featured speakers. Ionis, Denali Therapeutics and Germany's BfArM regulator also had speakers that year.
Who spoke at TIDES Europe: Oligonucleotide and Peptide Therapeutics 2026 (46)
- Nour Fahmi, PhD, Director, Chemistry, Eli Lilly and Company
- Jacob Challand Kofoed, PhD, Scientific Director, Peptide Research, Novo Nordisk
- Michael Kopach, PhD, Associate Vice President, Synthetic Molecule Design and Development, Eli Lilly and Company
- Claudia Höbartner, PhD, Professor of Organic Chemistry, University of Würzburg
- Gerard Platenburg, PhD, Chief Scientific Officer, ProQR Therapeutics
- Yogesh S. Sanghvi, PhD, President, Rasayan Inc.
- Paul Nioi, PhD, SVP, Alnylam Pharmaceuticals
- David J. Craik, PhD, Professor of Biomolecular Structure, University of Queensland
- Ashish Sarode, PhD, Director, Delivery & Formulations, mRNA Center of Excellence, Sanofi
- Federico Di Chiaro, Senior CMC Project Manager, Zealand Pharma
- El Djouhar Rekaï, PhD, Process & Analytical Development Director, PolyPeptide Group
- Eleonora Marino, Pharmaceutical Quality Specialist, European Medicines Agency
- Brian Dooley, Pharmaceutical Quality Senior Specialist, European Medicines Agency
- Tracey Burr, PhD, Executive Director, CMC Regulatory Affairs, Ionis Pharmaceuticals
- Joshua Brooks, PhD, Senior Director, Alnylam Pharmaceuticals
- Stephanie Coffin, Executive Director, Eli Lilly and Company
- Shanthi Ganesh, Director, Novo Nordisk
- Hannah Bolt, PhD, MBA, Head of Peptide Discovery, AstraZeneca
- Mathieu Cinier, Chief Scientific Officer, Affilogic
- Sonja Merkas, PhD, Founder and CEO, Livinovea
- Armin Delavari, PhD, Senior Scientist, ASO Purification Process Development, Biogen
- Troels Koch, PhD, Chief Technology Officer, Cora Biosciences
- Peter Hagedorn, Senior Director, Head of Bioinformatics, Contera Pharma
- Robert Place, Chief Technology Officer, MiNA Therapeutics
- John Lopez, PhD, Associate Director Science & Technology, Novartis
- William Fang, Vice President of Oligonucleotide and Peptide Development, WuXi TIDES
- Lin Chen, PhD, Associate Vice President, Peptide Manufacturing Technology and R&D, Asymchem
- Wuming Yan, Chief Scientist Oligonucleotides, Asymchem
- Kris Choi, Senior Vice President, Marketing and Business Development, ST Pharm
- Stephen Lock, PhD, Senior Market Development Manager, Biopharma, EMEAI, SCIEX
- Pachamuthu Kandasamy, PhD, Vice President, Medicinal Chemistry, Wave Life Sciences
- Lucas Bethge, PhD, VP, Group Leader Chemistry, Silence Therapeutics
- Jeremie Boucher, SVP, Head of Metabolic Disease, Evotec
- Mark Frigerio, Vice President, Head of Platform Technology & Science, Bicycle Therapeutics
- Chris Chorley, Regulatory Program Director, Roche
- Anja Beschnitt, PhD, Associate Director Analytical Development, BioNTech SE
- Florian Mann, PhD, Principal Scientist RNA Delivery & Non-Viral Vector Platform Lead, Bayer AG
- Jigna Dave, Regulatory Manager, CMC, GSK
- Daniel A. Briere, Senior Director, Cardiometabolic Research, Eli Lilly and Company
- Mimoun Ayoub, PhD, Senior VP, Global Head of Peptide and Oligonucleotide Platforms, CordenPharma International
- Carolin Lechner, PhD, Director R&D, Bachem
- Thomas Rupp, Vice President, CMC Strategy, Axolabs Berlin GmbH
- Tobias Merkle, PhD, Vice President Platform Development, AIRNA
- Kosh Neupane, PhD, Associate Director, AOC Process Development & Manufacturing, Avidity Biosciences
- Gabe Smolarz, VP Medical Affairs, Zealand Pharma
- Fernando Albericio, PhD, Research Professor, University of KwaZulu-Natal
Who spoke at TIDES Europe: Oligonucleotide and Peptide Therapeutics 2025 (7)
- Shalini Andersson, PhD, Vice President of Oligonucleotide Discovery, AstraZeneca
- Chris Hart, PhD, VP, Data Science and AI/ML, Eli Lilly and Company
- Jennifer Franklin, Executive Director, CMC Regulatory Affairs, Ionis Pharmaceuticals
- Firoz D. Antia, PhD, Vice President, Oligonucleotide & Small Molecule CMC, Denali Therapeutics
- Peter 't Hart, PhD, Professor of Molecular Biochemistry, University of Münster
- René Thürmer, PhD, Deputy Head, BfArM Federal Institute for Drugs and Medical Devices
- Nathalie Grob, PhD, Assistant Professor, ETH Zurich
Dates, venue and getting there
TIDES Europe 2027 dates and venue aren't announced yet. As of 6 November 2026, the TIDES series calendar lists TIDES Asia and TIDES USA for 2027 but no European edition.
The 2026 edition ran 3 to 5 November at the RAI Amsterdam Convention Centre, Europaplein 24. The post-event obesity symposium followed on 6 November.
For 2026 the venue and transportation page said Metro 52 from Amsterdam Central Station reaches Europaplein station in about six minutes. Tram 4 also stops at Europaplein.
Schiphol Airport is about 10 minutes from the RAI by train, according to the RAI Amsterdam route page. The 2025 edition was held in Basel.
Tickets and registration for TIDES Europe
Passes for TIDES Europe 2027 aren't on sale yet. In 2026 the event sold paid passes with separate rates for industry, academic, government and non-profit delegates.
In-person industry passes for 2026 started at £3,499 plus 21% VAT for the main conference, checked in October 2026.
Adding a morning workshop raised the 2026 industry price to £3,899 plus VAT. An all-access pass with the workshop and the obesity symposium cost £5,099 plus VAT.
Teams of three or more saved 10% to 50% on group rates in 2026, depending on size. A young company rate was open to small drug developers, but not to suppliers or sales staff.
Those who couldn't travel could buy a Digital Experience Pass. It included live streams, 12 months of recordings and the full attendee list on ConnectMe.
History of TIDES Europe
TIDES Europe is the European edition of the TIDES series, which also runs TIDES USA and TIDES Asia. All three are produced by Informa Connect.
The 2025 edition took place 11 to 13 November 2025 at Congress Center Basel in Switzerland. Nucleic Acid Insights previewed it as one of Europe's leading nucleic acid therapeutics events.
For 2026 the event moved to Amsterdam, which the organizer called Europe's hub for pharma and biotech. It ran at the RAI from 3 to 5 November 2026.
Resources for exhibitors, sponsors and attendees
These official pages cover the series calendar, registration, the 2026 program, exhibiting and travel.
- TIDES Europe home pageFor news of the 2027 dates and venue.
- TIDES series calendarFor upcoming TIDES Europe, USA and Asia dates.
- Registration packagesShowing pass options and the 2026 prices.
- Digital Experience PassFor remote access to streams and recordings.
- Group ratesFor teams of three or more.
- 2026 day one agendaWith workshops and keynotes, plus day two and day three.
- Speaker listWith the 2026 speakers.
- Sponsors and exhibitorsWith 2026 tiers, exhibitors and media partners.
- Why sponsorFor sponsorship, exhibit and digital options.
- Poster presentationsFor abstract rules and digital posters.
- ConnectMe appFor networking and meeting scheduling.
- Venue and transportationFor directions to RAI Amsterdam, the 2026 venue.